Medical Care

Global Viral and Non Viral Vector Manufacturing Market Research Report 2025

The global market for Viral and Non Viral Vector Manufacturing was valued at US$ 1783 million in the year 2024 and is projected to reach a revised size of US$ 4045 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Viral and non-viral vector manufacturing are processes involved in the production of delivery vehicles used in gene therapy and vaccine development. These vectors are carriers designed to transport genetic material (such as DNA or RNA) into target cells, facilitating the introduction of therapeutic genes or the expression of specific proteins.
Continued efforts to optimize and develop cell lines for viral vector production, including adherent and suspension cell culture systems.
This report aims to provide a comprehensive presentation of the global market for Viral and Non Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non Viral Vector Manufacturing.
The Viral and Non Viral Vector Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral and Non Viral Vector Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral and Non Viral Vector Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Catalent
Fujifilm Holdings Corporation
Danaher Corporation
Rescript Biotech Corporation
Lonza Group Ag
Merck Kagan
Oxford Biomedical Plc
Sartorius Ag
Takara Bio
Thermo Fisher Scientific
Wuxi Optec
Acuities Therapeutic
Evonik Industries Ag
Exiled
Entos Pharmaceuticals
Genevant Sciences Gmbh
T&T Scientific Corporation
Moderna
Curevac Nv
Segment by Type
Viral Vector
Non-viral Vector
Segment by Application
Gene Therapy
Vaccinology
Cell Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral and Non Viral Vector Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Vector
1.2.3 Non-viral Vector
1.3 Market by Application
1.3.1 Global Viral and Non Viral Vector Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.3.4 Cell Therapy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral and Non Viral Vector Manufacturing Market Perspective (2020-2031)
2.2 Global Viral and Non Viral Vector Manufacturing Growth Trends by Region
2.2.1 Global Viral and Non Viral Vector Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral and Non Viral Vector Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Viral and Non Viral Vector Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Viral and Non Viral Vector Manufacturing Market Dynamics
2.3.1 Viral and Non Viral Vector Manufacturing Industry Trends
2.3.2 Viral and Non Viral Vector Manufacturing Market Drivers
2.3.3 Viral and Non Viral Vector Manufacturing Market Challenges
2.3.4 Viral and Non Viral Vector Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral and Non Viral Vector Manufacturing Players by Revenue
3.1.1 Global Top Viral and Non Viral Vector Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Viral and Non Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral and Non Viral Vector Manufacturing Revenue
3.4 Global Viral and Non Viral Vector Manufacturing Market Concentration Ratio
3.4.1 Global Viral and Non Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral and Non Viral Vector Manufacturing Revenue in 2024
3.5 Global Key Players of Viral and Non Viral Vector Manufacturing Head office and Area Served
3.6 Global Key Players of Viral and Non Viral Vector Manufacturing, Product and Application
3.7 Global Key Players of Viral and Non Viral Vector Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral and Non Viral Vector Manufacturing Breakdown Data by Type
4.1 Global Viral and Non Viral Vector Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Viral and Non Viral Vector Manufacturing Forecasted Market Size by Type (2026-2031)
5 Viral and Non Viral Vector Manufacturing Breakdown Data by Application
5.1 Global Viral and Non Viral Vector Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Viral and Non Viral Vector Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral and Non Viral Vector Manufacturing Market Size (2020-2031)
6.2 North America Viral and Non Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025)
6.4 North America Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral and Non Viral Vector Manufacturing Market Size (2020-2031)
7.2 Europe Viral and Non Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025)
7.4 Europe Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Viral and Non Viral Vector Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral and Non Viral Vector Manufacturing Market Size (2020-2031)
9.2 Latin America Viral and Non Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Viral and Non Viral Vector Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Introduction
11.1.4 Boehringer Ingelheim Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Viral and Non Viral Vector Manufacturing Introduction
11.2.4 Catalent Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Fujifilm Holdings Corporation
11.3.1 Fujifilm Holdings Corporation Company Details
11.3.2 Fujifilm Holdings Corporation Business Overview
11.3.3 Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Introduction
11.3.4 Fujifilm Holdings Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.3.5 Fujifilm Holdings Corporation Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Viral and Non Viral Vector Manufacturing Introduction
11.4.4 Danaher Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.4.5 Danaher Corporation Recent Development
11.5 Rescript Biotech Corporation
11.5.1 Rescript Biotech Corporation Company Details
11.5.2 Rescript Biotech Corporation Business Overview
11.5.3 Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Introduction
11.5.4 Rescript Biotech Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.5.5 Rescript Biotech Corporation Recent Development
11.6 Lonza Group Ag
11.6.1 Lonza Group Ag Company Details
11.6.2 Lonza Group Ag Business Overview
11.6.3 Lonza Group Ag Viral and Non Viral Vector Manufacturing Introduction
11.6.4 Lonza Group Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.6.5 Lonza Group Ag Recent Development
11.7 Merck Kagan
11.7.1 Merck Kagan Company Details
11.7.2 Merck Kagan Business Overview
11.7.3 Merck Kagan Viral and Non Viral Vector Manufacturing Introduction
11.7.4 Merck Kagan Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.7.5 Merck Kagan Recent Development
11.8 Oxford Biomedical Plc
11.8.1 Oxford Biomedical Plc Company Details
11.8.2 Oxford Biomedical Plc Business Overview
11.8.3 Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Introduction
11.8.4 Oxford Biomedical Plc Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.8.5 Oxford Biomedical Plc Recent Development
11.9 Sartorius Ag
11.9.1 Sartorius Ag Company Details
11.9.2 Sartorius Ag Business Overview
11.9.3 Sartorius Ag Viral and Non Viral Vector Manufacturing Introduction
11.9.4 Sartorius Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.9.5 Sartorius Ag Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Viral and Non Viral Vector Manufacturing Introduction
11.10.4 Takara Bio Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Introduction
11.11.4 Thermo Fisher Scientific Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Wuxi Optec
11.12.1 Wuxi Optec Company Details
11.12.2 Wuxi Optec Business Overview
11.12.3 Wuxi Optec Viral and Non Viral Vector Manufacturing Introduction
11.12.4 Wuxi Optec Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.12.5 Wuxi Optec Recent Development
11.13 Acuities Therapeutic
11.13.1 Acuities Therapeutic Company Details
11.13.2 Acuities Therapeutic Business Overview
11.13.3 Acuities Therapeutic Viral and Non Viral Vector Manufacturing Introduction
11.13.4 Acuities Therapeutic Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.13.5 Acuities Therapeutic Recent Development
11.14 Evonik Industries Ag
11.14.1 Evonik Industries Ag Company Details
11.14.2 Evonik Industries Ag Business Overview
11.14.3 Evonik Industries Ag Viral and Non Viral Vector Manufacturing Introduction
11.14.4 Evonik Industries Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.14.5 Evonik Industries Ag Recent Development
11.15 Exiled
11.15.1 Exiled Company Details
11.15.2 Exiled Business Overview
11.15.3 Exiled Viral and Non Viral Vector Manufacturing Introduction
11.15.4 Exiled Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.15.5 Exiled Recent Development
11.16 Entos Pharmaceuticals
11.16.1 Entos Pharmaceuticals Company Details
11.16.2 Entos Pharmaceuticals Business Overview
11.16.3 Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Introduction
11.16.4 Entos Pharmaceuticals Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.16.5 Entos Pharmaceuticals Recent Development
11.17 Genevant Sciences Gmbh
11.17.1 Genevant Sciences Gmbh Company Details
11.17.2 Genevant Sciences Gmbh Business Overview
11.17.3 Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Introduction
11.17.4 Genevant Sciences Gmbh Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.17.5 Genevant Sciences Gmbh Recent Development
11.18 T&T Scientific Corporation
11.18.1 T&T Scientific Corporation Company Details
11.18.2 T&T Scientific Corporation Business Overview
11.18.3 T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Introduction
11.18.4 T&T Scientific Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.18.5 T&T Scientific Corporation Recent Development
11.19 Moderna
11.19.1 Moderna Company Details
11.19.2 Moderna Business Overview
11.19.3 Moderna Viral and Non Viral Vector Manufacturing Introduction
11.19.4 Moderna Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.19.5 Moderna Recent Development
11.20 Curevac Nv
11.20.1 Curevac Nv Company Details
11.20.2 Curevac Nv Business Overview
11.20.3 Curevac Nv Viral and Non Viral Vector Manufacturing Introduction
11.20.4 Curevac Nv Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025)
11.20.5 Curevac Nv Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Vector
Table 3. Key Players of Non-viral Vector
Table 4. Global Viral and Non Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Viral and Non Viral Vector Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Viral and Non Viral Vector Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Viral and Non Viral Vector Manufacturing Market Share by Region (2020-2025)
Table 8. Global Viral and Non Viral Vector Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Viral and Non Viral Vector Manufacturing Market Share by Region (2026-2031)
Table 10. Viral and Non Viral Vector Manufacturing Market Trends
Table 11. Viral and Non Viral Vector Manufacturing Market Drivers
Table 12. Viral and Non Viral Vector Manufacturing Market Challenges
Table 13. Viral and Non Viral Vector Manufacturing Market Restraints
Table 14. Global Viral and Non Viral Vector Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Viral and Non Viral Vector Manufacturing Market Share by Players (2020-2025)
Table 16. Global Top Viral and Non Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non Viral Vector Manufacturing as of 2024)
Table 17. Ranking of Global Top Viral and Non Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Viral and Non Viral Vector Manufacturing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Viral and Non Viral Vector Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Viral and Non Viral Vector Manufacturing, Product and Application
Table 21. Global Key Players of Viral and Non Viral Vector Manufacturing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral and Non Viral Vector Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Type (2020-2025)
Table 25. Global Viral and Non Viral Vector Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Type (2026-2031)
Table 27. Global Viral and Non Viral Vector Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Application (2020-2025)
Table 29. Global Viral and Non Viral Vector Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Viral and Non Viral Vector Manufacturing Revenue Market Share by Application (2026-2031)
Table 31. North America Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Boehringer Ingelheim Company Details
Table 47. Boehringer Ingelheim Business Overview
Table 48. Boehringer Ingelheim Viral and Non Viral Vector Manufacturing Product
Table 49. Boehringer Ingelheim Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 50. Boehringer Ingelheim Recent Development
Table 51. Catalent Company Details
Table 52. Catalent Business Overview
Table 53. Catalent Viral and Non Viral Vector Manufacturing Product
Table 54. Catalent Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Fujifilm Holdings Corporation Company Details
Table 57. Fujifilm Holdings Corporation Business Overview
Table 58. Fujifilm Holdings Corporation Viral and Non Viral Vector Manufacturing Product
Table 59. Fujifilm Holdings Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 60. Fujifilm Holdings Corporation Recent Development
Table 61. Danaher Corporation Company Details
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Viral and Non Viral Vector Manufacturing Product
Table 64. Danaher Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. Rescript Biotech Corporation Company Details
Table 67. Rescript Biotech Corporation Business Overview
Table 68. Rescript Biotech Corporation Viral and Non Viral Vector Manufacturing Product
Table 69. Rescript Biotech Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 70. Rescript Biotech Corporation Recent Development
Table 71. Lonza Group Ag Company Details
Table 72. Lonza Group Ag Business Overview
Table 73. Lonza Group Ag Viral and Non Viral Vector Manufacturing Product
Table 74. Lonza Group Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 75. Lonza Group Ag Recent Development
Table 76. Merck Kagan Company Details
Table 77. Merck Kagan Business Overview
Table 78. Merck Kagan Viral and Non Viral Vector Manufacturing Product
Table 79. Merck Kagan Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 80. Merck Kagan Recent Development
Table 81. Oxford Biomedical Plc Company Details
Table 82. Oxford Biomedical Plc Business Overview
Table 83. Oxford Biomedical Plc Viral and Non Viral Vector Manufacturing Product
Table 84. Oxford Biomedical Plc Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 85. Oxford Biomedical Plc Recent Development
Table 86. Sartorius Ag Company Details
Table 87. Sartorius Ag Business Overview
Table 88. Sartorius Ag Viral and Non Viral Vector Manufacturing Product
Table 89. Sartorius Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 90. Sartorius Ag Recent Development
Table 91. Takara Bio Company Details
Table 92. Takara Bio Business Overview
Table 93. Takara Bio Viral and Non Viral Vector Manufacturing Product
Table 94. Takara Bio Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 95. Takara Bio Recent Development
Table 96. Thermo Fisher Scientific Company Details
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Viral and Non Viral Vector Manufacturing Product
Table 99. Thermo Fisher Scientific Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Wuxi Optec Company Details
Table 102. Wuxi Optec Business Overview
Table 103. Wuxi Optec Viral and Non Viral Vector Manufacturing Product
Table 104. Wuxi Optec Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 105. Wuxi Optec Recent Development
Table 106. Acuities Therapeutic Company Details
Table 107. Acuities Therapeutic Business Overview
Table 108. Acuities Therapeutic Viral and Non Viral Vector Manufacturing Product
Table 109. Acuities Therapeutic Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 110. Acuities Therapeutic Recent Development
Table 111. Evonik Industries Ag Company Details
Table 112. Evonik Industries Ag Business Overview
Table 113. Evonik Industries Ag Viral and Non Viral Vector Manufacturing Product
Table 114. Evonik Industries Ag Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 115. Evonik Industries Ag Recent Development
Table 116. Exiled Company Details
Table 117. Exiled Business Overview
Table 118. Exiled Viral and Non Viral Vector Manufacturing Product
Table 119. Exiled Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 120. Exiled Recent Development
Table 121. Entos Pharmaceuticals Company Details
Table 122. Entos Pharmaceuticals Business Overview
Table 123. Entos Pharmaceuticals Viral and Non Viral Vector Manufacturing Product
Table 124. Entos Pharmaceuticals Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 125. Entos Pharmaceuticals Recent Development
Table 126. Genevant Sciences Gmbh Company Details
Table 127. Genevant Sciences Gmbh Business Overview
Table 128. Genevant Sciences Gmbh Viral and Non Viral Vector Manufacturing Product
Table 129. Genevant Sciences Gmbh Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 130. Genevant Sciences Gmbh Recent Development
Table 131. T&T Scientific Corporation Company Details
Table 132. T&T Scientific Corporation Business Overview
Table 133. T&T Scientific Corporation Viral and Non Viral Vector Manufacturing Product
Table 134. T&T Scientific Corporation Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 135. T&T Scientific Corporation Recent Development
Table 136. Moderna Company Details
Table 137. Moderna Business Overview
Table 138. Moderna Viral and Non Viral Vector Manufacturing Product
Table 139. Moderna Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 140. Moderna Recent Development
Table 141. Curevac Nv Company Details
Table 142. Curevac Nv Business Overview
Table 143. Curevac Nv Viral and Non Viral Vector Manufacturing Product
Table 144. Curevac Nv Revenue in Viral and Non Viral Vector Manufacturing Business (2020-2025) & (US$ Million)
Table 145. Curevac Nv Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report


List of Figures
Figure 1. Viral and Non Viral Vector Manufacturing Picture
Figure 2. Global Viral and Non Viral Vector Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral and Non Viral Vector Manufacturing Market Share by Type: 2024 VS 2031
Figure 4. Viral Vector Features
Figure 5. Non-viral Vector Features
Figure 6. Global Viral and Non Viral Vector Manufacturing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Viral and Non Viral Vector Manufacturing Market Share by Application: 2024 VS 2031
Figure 8. Gene Therapy Case Studies
Figure 9. Vaccinology Case Studies
Figure 10. Cell Therapy Case Studies
Figure 11. Others Case Studies
Figure 12. Viral and Non Viral Vector Manufacturing Report Years Considered
Figure 13. Global Viral and Non Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Viral and Non Viral Vector Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Viral and Non Viral Vector Manufacturing Market Share by Region: 2024 VS 2031
Figure 16. Global Viral and Non Viral Vector Manufacturing Market Share by Players in 2024
Figure 17. Global Top Viral and Non Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non Viral Vector Manufacturing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Viral and Non Viral Vector Manufacturing Revenue in 2024
Figure 19. North America Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Viral and Non Viral Vector Manufacturing Market Share by Country (2020-2031)
Figure 21. United States Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Viral and Non Viral Vector Manufacturing Market Share by Country (2020-2031)
Figure 25. Germany Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Viral and Non Viral Vector Manufacturing Market Share by Region (2020-2031)
Figure 33. China Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Viral and Non Viral Vector Manufacturing Market Share by Country (2020-2031)
Figure 41. Mexico Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Viral and Non Viral Vector Manufacturing Market Share by Country (2020-2031)
Figure 45. Turkey Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Viral and Non Viral Vector Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 49. Catalent Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 50. Fujifilm Holdings Corporation Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 51. Danaher Corporation Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 52. Rescript Biotech Corporation Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 53. Lonza Group Ag Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 54. Merck Kagan Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 55. Oxford Biomedical Plc Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 56. Sartorius Ag Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 57. Takara Bio Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 59. Wuxi Optec Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 60. Acuities Therapeutic Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 61. Evonik Industries Ag Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 62. Exiled Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 63. Entos Pharmaceuticals Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 64. Genevant Sciences Gmbh Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 65. T&T Scientific Corporation Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 66. Moderna Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 67. Curevac Nv Revenue Growth Rate in Viral and Non Viral Vector Manufacturing Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies